Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker GUTS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | William Bradley Director | GUTS Fractyl Health, Inc. | Buy | 64,516 | $0.62 | $40.0K Buy | Form 4 ↗ |
| Jun 12, 2026 | Ajay Royan Director | GUTS Fractyl Health, Inc. | Buy | 23,000 | $0.85 | $19.6K Buy | Form 4 ↗ |
| Jun 10, 2026 | William Bradley Director | GUTS Fractyl Health, Inc. | Buy | 68,493 | $0.73 | $50.0K Buy | Form 4 ↗ |
| Jun 10, 2026 | Ian Sheffield Director | GUTS Fractyl Health, Inc. | Buy | 35,000 | $0.73 | $25.6K Buy | Form 4 ↗ |
| Jun 10, 2026 | Harith Rajagopalan Chief Executive Officer, Director | GUTS Fractyl Health, Inc. | Buy | 25,000 | $0.73 | $18.3K Buy | Form 4 ↗ |
| Jun 8, 2026 | Weber Lara Smith Chief Financial Officer | GUTS Fractyl Health, Inc. | Buy | 20,000 | $0.69 | $13.8K Buy | Form 4 ↗ |
| Dec 4, 2025 | Harith Rajagopalan Chief Executive Officer, Director | GUTS Fractyl Health, Inc. | Buy | 10,416 | $1.92 | $20.0K Buy | Form 4 ↗ |
| Mar 14, 2025 | Ajay Royan Director, 10% owner | GUTS Fractyl Health, Inc. | Buy | 17,901 | $1.28 | $22.9K Buy | Form 4 ↗ |
| Mar 14, 2025 | Kelly Ann Barnes Director | GUTS Fractyl Health, Inc. | Buy | 31,000 | $1.30 | $40.3K Buy | Form 4 ↗ |
| Mar 13, 2025 | Amy W. Schulman Director | GUTS Fractyl Health, Inc. | Buy | 8,550 | $1.17 | $10.0K Buy | Form 4 ↗ |
| Mar 13, 2025 | William Bradley Director | GUTS Fractyl Health, Inc. | Buy | 16,129 | $1.26 | $20.3K Buy | Form 4 ↗ |
| Jan 31, 2025 | Harith Rajagopalan Chief Executive Officer, Director | GUTS Fractyl Health, Inc. | Sale | 90,972 | $1.82 | $165.6K Sale | Form 4 ↗ |
| Jan 31, 2025 | Jay David Caplan President, Chief Product Off. | GUTS Fractyl Health, Inc. | Sale | 22,346 | $1.81 | $40.4K Sale | Form 4 ↗ |
| Jan 30, 2025 | Harith Rajagopalan Chief Executive Officer, Director | GUTS Fractyl Health, Inc. | Sale | 20,948 | $1.95 | $40.8K Sale | Form 4 ↗ |
| Jan 30, 2025 | Jay David Caplan President, Chief Product Off. | GUTS Fractyl Health, Inc. | Sale | 21,472 | $1.95 | $41.9K Sale | Form 4 ↗ |
| Nov 11, 2024 | Harith Rajagopalan Chief Executive Officer, Director | GUTS Fractyl Health, Inc. | Sale | 96,517 | $2.47 | $238.4K Sale | Form 4 ↗ |
| Nov 11, 2024 | Jay David Caplan President, Chief Product Off. | GUTS Fractyl Health, Inc. | Sale | 64,197 | $2.47 | $158.6K Sale | Form 4 ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances